Biogen, Eisai Get FDA Nod for Leqembi IV Maintenance Dosing
Biogen and Eisai have won Food and Drug Administration approval of an intravenous maintenance dosing of their Leqembi drug for early Alzheimer's disease. The companies late Sunday said the FDA approved the maintenance dosing of once every four weeks after 18 months of the initiation phase of once every two weeks.
The post 3 Furnace Maintenance Tips Recommended by HVAC Experts To Save You Money appeared first on Real Estate News & ...
The Indiana Department of Transportation (INDOT) has announced that starting on January 27, crews will be closing State Road ...
Maintenance costs are a significant factor for many buyers when selecting an SUV. While SUVs offer numerous advantages, such ...
FOX 35 Orlando on MSN1d
Florida apartment maintenance worker arrested after allegedly stealing, selling 33 jewelry piecesDeputies said they arrested a Florida apartment maintenance worker after he allegedly stole and sold 33 jewelry items at 10 ...
For organizations considering the adoption of scalable AI for demand forecasting, it’s essential to approach implementation ...
MoDOT announces maintenance in the Kansas City area from Jan 27-31, weather permitting, impacting several routes.
When it comes to safeguarding the community from the destructive power of heavy rains and flooding, Woodlands Water is taking ...
The National Audit Office Ministers has also warned ministers that allowing the waiting list of repairs to linger is a ‘false ...
Convenience has become a priority for consumers. From streaming services to meal kits, subscription models have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback